Related references
Note: Only part of the references are listed.The Pathogenesis of Sepsis
Deborah J. Stearns-Kurosawa et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
A play in four acts: Staphylococcus aureus abscess formation
Alice G. Cheng et al.
TRENDS IN MICROBIOLOGY (2011)
Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactions
Alex J. McCarthy et al.
BMC MICROBIOLOGY (2010)
Clumping Factor A Interaction with Complement Factor I Increases C3b Cleavage on the Bacterial Surface of Staphylococcus aureus and Decreases Complement-Mediated Phagocytosis
Pamela S. Hair et al.
INFECTION AND IMMUNITY (2010)
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis
Mitchell M. Levy et al.
INTENSIVE CARE MEDICINE (2010)
Dabigatran Inhibits Staphylococcus aureus Coagulase Activity
Thomas Vanassche et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Community-associated meticillin-resistant Staphylococcus aureus
Frank R. DeLeo et al.
LANCET (2010)
IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge
Hwan Keun Kim et al.
VACCINE (2010)
Contribution of Coagulases towards Staphylococcus aureus Disease and Protective Immunity
Alice G. Cheng et al.
PLOS PATHOGENS (2010)
Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study)
Fabian Jaimes et al.
CRITICAL CARE MEDICINE (2009)
Waves of resistance: Staphylococcus aureus in the antibiotic era
Henry F. Chambers et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Structure of the fibrinogen γ-chain integrin binding and factor XIIIa cross-linking sites obtained through carrier protein driven crystallization
Scott Ware et al.
PROTEIN SCIENCE (2009)
The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States
R. Monina Klevens et al.
CLINICAL INFECTIOUS DISEASES (2008)
Signal peptides direct surface proteins to two distinct envelope locations of Staphylococcus aureus
Andrea DeDent et al.
EMBO JOURNAL (2008)
Identification of the Staphylococcus aureus MSCRAMM clumping factor B (ClfB) binding site in the αC-domain of human fibrinogen
Evelyn J. Walsh et al.
MICROBIOLOGY-SGM (2008)
A Structural Model of the Staphylococcus aureus ClfA-Fibrinogen Interaction Opens New Avenues for the Design of Anti-Staphylococcal Therapeutics
Vannakambadi K. Ganesh et al.
PLOS PATHOGENS (2008)
Genome sequence of Staphylococcus aureus strain newman and comparative analysis of staphylococcal genomes: Polymorphism and evolution of two major pathogenicity islands
Tadashi Baba et al.
JOURNAL OF BACTERIOLOGY (2008)
Invasive methicillin-resistant Staphylococcus aureus infections in the United States
R. Monina Klevens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Thrombin generation and fibrin clot structure
Alisa S. Wolberg
BLOOD REVIEWS (2007)
Vaccine assembly from surface proteins of Staphylococcus aureus
Yukiko K. Stranger-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia
J. John Weems et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus
BA Diep et al.
LANCET (2006)
Fibrinogen substrate recognition by Staphylocoagulase•(pro) thrombin complexes
P Panizzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Drug therapy -: Direct thrombin inhibitors
M Di Nisio et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Staphylococcus aureus endocarditis -: A consequence of medical progress
VG Fowler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism
T Jin et al.
JOURNAL OF IMMUNOLOGY (2004)
Staphylocloccus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing
T Bae et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A
AE Hall et al.
INFECTION AND IMMUNITY (2003)
Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation
R Friedrich et al.
NATURE (2003)
Argatroban inhibits staphylothrombin
A Hijikata-Okunomiya et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
The epidemiology of sepsis in the United States from 1979 through 2000
GS Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Structural basis of the fibrinogen-fibrin transformation: contributions from X-ray crystallography
RF Doolittle
BLOOD REVIEWS (2003)
A novel von Willebrand factor binding protein expressed by Staphylococcus aureus
J Bjerketorp et al.
MICROBIOLOGY-SGM (2002)
Genome and virulence determinants of high virulence community-acquired MRSA
T Baba et al.
LANCET (2002)
Structure-based design of novel potent nonpeptide thrombin inhibitors
NH Hauel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinase
T Mölkänen et al.
FEBS LETTERS (2002)
Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant
E Josefsson et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Whole genome sequencing of meticillin-resistant Staphylococcus aureus
M Kuroda et al.
LANCET (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections
SK Mazmanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
